Back to All Events

Medtech Canada Speaker Series: Insured for Innovation: Protecting Canadian Medtech from Concept to Commercialization

Medtech Canada Speaker Series

Insured for Innovation: Protecting Canadian Medtech from Concept to Commercialization

Medical technology companies carry a risk profile unlike any other - product liability, clinical trials, regulatory exposure, supply chain fragility, cyber and intellectual property, often all at once. In this session, David Kerr, Senior Vice President and National Life Sciences Practice Leader at Gallagher in Canada, will walk through who Gallagher is, how their CORE360 approach uncovers the full cost of risk across a business, the coverages most pertinent to medtech operations, and real claims examples that show where companies get exposed.

Attendees will leave knowing which gaps to close first and how Gallagher can help Medtech Canada members close them.

Previous
Previous
November 24

Expanding Canadian Health Tech to Baden-Württemberg

Next
Next
November 26

Designing for access: Women's health equity